These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 28675558)

  • 1. Clinical studies and anti-inflammatory mechanisms of treatments.
    French JA; Koepp M; Naegelin Y; Vigevano F; Auvin S; Rho JM; Rosenberg E; Devinsky O; Olofsson PS; Dichter MA
    Epilepsia; 2017 Jul; 58 Suppl 3(Suppl 3):69-82. PubMed ID: 28675558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and Epilepsy: Preclinical Findings and Potential Clinical Translation.
    Terrone G; Salamone A; Vezzani A
    Curr Pharm Des; 2017; 23(37):5569-5576. PubMed ID: 28950818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis?
    Vezzani A
    Expert Opin Drug Saf; 2015 Apr; 14(4):583-92. PubMed ID: 25645535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammatory targets and treatments for epilepsy validated in experimental models.
    Aronica E; Bauer S; Bozzi Y; Caleo M; Dingledine R; Gorter JA; Henshall DC; Kaufer D; Koh S; Löscher W; Louboutin JP; Mishto M; Norwood BA; Palma E; Poulter MO; Terrone G; Vezzani A; Kaminski RM
    Epilepsia; 2017 Jul; 58 Suppl 3(Suppl 3):27-38. PubMed ID: 28675563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and reactive oxygen species as disease modifiers in epilepsy.
    Terrone G; Balosso S; Pauletti A; Ravizza T; Vezzani A
    Neuropharmacology; 2020 May; 167():107742. PubMed ID: 31421074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments.
    Löscher W
    Neuropharmacology; 2020 May; 167():107605. PubMed ID: 30980836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing epileptogenesis: A realistic goal?
    Terrone G; Pauletti A; Pascente R; Vezzani A
    Pharmacol Res; 2016 Aug; 110():96-100. PubMed ID: 27173399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroinflammation impact in epileptogenesis and new treatment strategy.
    Mahfoz AM; Shahzad N
    Behav Pharmacol; 2019 Dec; 30(8):661-675. PubMed ID: 31658099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
    Löscher W
    Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interweaving epilepsy and neurodegeneration: Vitamin E as a treatment approach.
    Upaganlawar AB; Wankhede NL; Kale MB; Umare MD; Sehgal A; Singh S; Bhatia S; Al-Harrasi A; Najda A; Nurzyńska-Wierdak R; Bungau S; Behl T
    Biomed Pharmacother; 2021 Nov; 143():112146. PubMed ID: 34507113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches.
    Vitaliti G; Pavone P; Mahmood F; Nunnari G; Falsaperla R
    Hum Vaccin Immunother; 2014; 10(4):868-75. PubMed ID: 24609096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.
    Dey A; Kang X; Qiu J; Du Y; Jiang J
    Trends Pharmacol Sci; 2016 Jun; 37(6):463-484. PubMed ID: 27062228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation in epileptogenesis: Insights and translational perspectives from new models of epilepsy.
    Barker-Haliski ML; Löscher W; White HS; Galanopoulou AS
    Epilepsia; 2017 Jul; 58 Suppl 3(Suppl 3):39-47. PubMed ID: 28675559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of new antiinflammatory drugs.
    Vezzani A; Bartfai T; Bianchi M; Rossetti C; French J
    Epilepsia; 2011 Oct; 52 Suppl 8():67-9. PubMed ID: 21967368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models in research of pharmacoresistant epilepsy: present and future in development of antiepileptic drugs.
    Kovács R; Heinemann U
    Curr Med Chem; 2014; 21(6):689-703. PubMed ID: 24251565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.
    Löscher W; Brandt C
    Pharmacol Rev; 2010 Dec; 62(4):668-700. PubMed ID: 21079040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain inflammation in epilepsy: experimental and clinical evidence.
    Vezzani A; Granata T
    Epilepsia; 2005 Nov; 46(11):1724-43. PubMed ID: 16302852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-epileptogenic clinical trial designs in epilepsy: issues and options.
    Schmidt D; Friedman D; Dichter MA
    Neurotherapeutics; 2014 Apr; 11(2):401-11. PubMed ID: 24420312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of inflammatory mediators in the pathogenesis of epilepsy.
    Shimada T; Takemiya T; Sugiura H; Yamagata K
    Mediators Inflamm; 2014; 2014():901902. PubMed ID: 25197169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.